Table 2

The results of repeated measures ANOVAs comparing the mean duration or accuracy of performance on the mCST in patients (N= 10) and healthy volunteers (N= 8)
Effects df; dferror F ptwo-tailed η2part Power
DURATION
PATIENT
TREATMENT 1; 9 5.7 .040* .39 .57
BLOCK 1; 9 14.3 .004* .61 .92
TREATMENT × BLOCK 1; 9 1.3 .276 .13 .18
HEALTHY VOLUNTEER
BREAK 1; 7 3.0 .126 .30 .32
BLOCK 1; 7 41.9 <.001* .86 1.00
BREAK × BLOCK 1; 7 3.9 .089 .36 .40
PATIENT
TIME 1; 9 25.7 .001* .74 .99
HEALTHY VOLUNTEER
TIME 1; 7 23.0 .002* .77 .98
ACCURACY
PATIENT
TREATMENT 1; 9 .2 .632 .03 .07
BLOCK 1; 9 21.2 .001* .70 .98
TREATMENT × BLOCK 1; 9 .7 .432 .07 .11
HEALTHY VOLUNTEER
BREAK 1; 7 .8 .406 .10 .12
BLOCK 1; 7 9.7 .017* .58 .76
BREAK × BLOCK 1; 7 .001 .970 <.01 .05
PATIENT
TIME 1; 9 31.4 <.001* .78 1.00
HEALTHY VOLUNTEER
TIME 1; 7 1.5 .256 .18 .19

df- degrees of freedom, η2part- partial eta squared (effect size). All ANOVAs were conducted using the following within-subject factors:

· TREATMENT: before vs. after rTMS.

· BLOCK: 1 = first 10 days vs. 2 = last 10 days of experiment.

· BREAK: before vs. after session break between the mCST administrations (equivalent to the time taken to administer rTMS in patients) in healthy volunteers.

· TIME: before rTMS or break on the first 10 days vs. after rTMS or break on the last 10 days of experiment.

*p < .05.

Kedzior et al.

Kedzior et al. BMC Psychiatry 2012 12:163   doi:10.1186/1471-244X-12-163

Open Data